C. Gustavo De Moraes, MD, PhD, MPH

Ophthalmology
Accepting New Patients
Profile Headshot

Profile Navigation

Overview

C. Gustavo De Moraes, MD, MPH – ColumbiaDoctors Ophthalmologists

Dr. C. Gustavo De Moraes is an Associate Professor of Clinical Ophthalmology at the Columbia University Medical Center and Attending Physician at New York Presbyterian Hospital. He sees patients with or at risk of developing glaucoma. His primary research interests are in novel techniques for glaucoma diagnosis, detection of progression, and treatment. Based on his research, Dr. De Moraes has been ranked among the top 10 glaucoma experts in the world, as cited at Expertscape.com.

Dr. De Moraes completed a glaucoma fellowship at the New York Eye and Ear Infirmary (NYEEI), later directing the Glaucoma Research Unit at the Einhorn Clinical Research Center of the NYEEI. He was also a Research Associate Professor of Ophthalmology at New York University (NYU).

Dr. De Moraes is a member of the American Medical Association (AMA), American College of Surgeons (ACS), American Academy of Ophthalmology (AAO), Association for Research in Vision and Ophthalmology (ARVO), American Glaucoma Society (AGS), New York Glaucoma Society (NYGS), Ophthalmic Laser and Imaging Society (OLIS). He is past chair of the Associate Advisory Board of the World Glaucoma Association (WGA), and Education Committee of the International Council of Ophthalmology (ICO). Dr. De Moraes is the current Associate Editor for the journal Investigative Ophthalmology and Vision Sciences (IOVS), and co-chair of Glaucoma Progression Scholas (GPS).

He has published over 250 articles in peer-reviewed journals and serves as a reviewer of the editorial boards of some journals with highest impact factor in the field of Ophthalmology. He has authored/ co-authored 5 book chapters in Ophthalmology and Glaucoma, as well as the Consensus on Medical Treatment and Consensus on Glaucoma Progression of the WGA.

Dr. De Moraes has twice received the American Academy of Ophthalmology (AAO) Achievement Award. His clinical research has been funded by the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Research to Prevent Blindness (RPB). 

To view a full listing of Dr. DeMoraes’ publications, click here.

Areas of Expertise / Conditions Treated

  • Clinical Research Trials
  • Glaucoma
  • Glaucoma Diabetic Eye Disease
  • Glaucoma Laser Surgery
  • Glaucoma Surgery
  • Visual Fields

Academic Appointments

  • Associate Professor of Clinical Ophthalmology at CUIMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Languages

  • German
  • Portuguese
  • Spanish

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
(212) 305-9535

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

CUIMC/Edward S. Harkness Eye Institute
622 W 168th Street
201B
New York, NY 10032
Disabled Accessible
Phone:
(212) 305-9535
Open location in Google Maps

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • HMO
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Quality Health Management

  • Quality Health Management

RiverSpring

  • Special Needs

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

World Trade Center Health Plan

  • World Trade Center Health Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • PhD, University of Sao Paulo, Faculty of Medicine (Brazil)
  • MPH, Columbia University Mailman School of Public Health
  • MD, 2003 University of Sao Paulo, Faculty of Medicine (Brazil)
  • Residency: 2008 University of Sao Paulo, Faculty of Medicine (Brazil)
  • Fellowship: 2007 University of Sao Paulo, Faculty of Medicine (Brazil)
  • Fellowship: 2009 New York Eye & Ear Infirmary

Committees, Societies, Councils

Association of Research in Vision and Ophthalmology (ARVO)

American Glaucoma Society (AGS)

New York Glaucoma Society (NYGS)

Research

Dr. C. Gustavo De Moraes is Associate Professor of Clinical Ophthalmology at at Columbia University Medical Center. His primary research interests are in novel techniques for glaucoma diagnosis and treatment. Based on his research, Dr. De Moraes has been ranked among the top 10 glaucoma experts in the world, as cited at Expertscape.com.

Dr. De Moraes completed a Glaucoma fellowship at the New York Eye and Ear Infirmary (NYEEI), followed by many years as Director of Glaucoma Research at the Einhorn Clinical Research Center of the NYEEI and Associate Professor of Ophthalmology at New York University (NYU).

Dr. De Moraes is a member of the American Medical Association (AMA), American Academy of Ophthalmology (AAO), Association for Research in Vision and Ophthalmology (ARVO), American Glaucoma Society (AGS), New York Glaucoma Society (NYGS), Ophthalmic Laser and Surgery Society (OLSS), and World Glaucoma Association (WGA).

He has published over 170 articles in peer-reviewed journals and is currently a member of the editorial boards of some of the journals with highest impact factor in the field of Ophthalmology. He has authored 5 book chapters in Ophthalmology and Glaucoma, and co-authored the Consensus on Medical Treatment of Glaucoma and Consensus on Glaucoma Progression of the World Glaucoma Association (WGA).

Dr. De Moraes is a member of the Education and Guidelines Committee of the International Council of Ophthalmology (ICO), co-chair of the Associate Advisory Board of the World Glaucoma Association (WGA), and member of the Publications Committee of the Association for Research in Vision and Ophthalmology (ARVO). In 2017, he received the American Academy of Ophthalmology (AAO) Achievement Award.

Dr. De Moraes’ clinical research is funded by the National Institutes of Health (NIH) and Research to Prevent Blindness (RPB), New York, NY.

Research Interests

  • Novel Techniques for glaucoma diagnosis and treatment

Selected Publications

Original, Peer Reviewed Articles:

1. DE MORAES CG, Castro Reis AS, de Sá Cavalcante AF, Sano ME, Susanna R Jr. Choroidal expansion during the water drinking test. Graefes Arch Clin Exp Ophthalmol. 2009;247(3):385-389

2. DE MORAES CG, Susanna R Jr. Correlation between the water drinking test and modified diurnal tension curve in untreated glaucomatous eyes. Clinics. 2008;63(4):433-436

3. Prata TS, Palmiero PM, Angelilli A, Sbeity Z, DE MORAES CG, Liebmann J, Ritch R. Iris Morphological Changes Related to Alpha-1 Adrenergic Receptor Antagonists: Implications for Intraoperative Floppy Iris Syndrome. Ophthalmology 2009;116:877-881

4. DE MORAES CG, Castro Reis AS, Vegini F, Cavalcanti, NF, Sano ME, Susanna R Jr. Agreement between stress intraocular pressure and long term intraocular pressure measurements in primary open angle glaucoma. Clinical and Experimental Ophthalmology 2009;37:270-274

5. DE MORAES CG, Castro Reis AS, Barreira AK, Sano ME, Vessani RM, Susanna R Jr. Intraocular pressure profile during the modified diurnal tension curve using Goldman and Pascal Dynamic Contour Tonometry. Journal of Ocular Biology, Diseases and Informatics 2009;2:29-32

6. Prata TS, Mehta A, DE MORAES CG, Tello C, Liebmann J, Ritch R. Baerveldt Glaucoma Implant in the Ciliary Sulcus: Midterm Follow-up. J Glaucoma. 2010;:15-18

7. Wang M, DE MORAES CG, Liebmann J, Ritch R, Hood DC. Local retinal ganglion cell layer thickness can be measured in patients with glaucoma using frequency-domain optical coherence tomography. Arch Ophthalmol. 2009;127:875-881

8. DE MORAES CG, Prata TS, Tello C, Ritch R, Liebmann JM. Glaucoma with visual field loss affecting both hemifields increases the risk of disease progression. Arch Ophthalmol. 2009;127:1129-1134.

9. DE MORAES CG, Prata TS, Tello C, Ritch R, Liebmann JM. Spatially-consistent localized visual field loss before and after disc hemorrhage. Invest Ophthalmol Vis Sci. 2009;50:4727-4733

10. Facio AC, Reis AS, Vidal KS, DE MORAES CG, Suzuki R, Hatanaka M, Susanna R. A comparison of bimatoprost 0.03% versus the fixed-combination of latanotoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial. J Ocul Pharmacol Ther. 2009;25:447-451

11. Prata TS, DE MORAES CG, Teng CC, Tello C, Ritch R, Liebmann JM. Factors Affecting Rates of Visual Field Progression in Glaucoma Patients with Optic Disc Hemorrhage. Ophthalmology. 2009;116:24-29

12. Prata TS, DE MORAES CG, Dorairaj S, Liebmann JM, Ritch R. Indentation slit lamp-adapted optical coherence tomography technique for anterior chamber angle assessment. Arch Ophthalmol. 2010;128:646-647

13. Ritch R, Prata TS, DE MORAES CG, Vessani RM, Costa VP, Konstas AGP, Liebmann J, Schlötzer-Schrehardt U. Association of exfoliation syndrome and central retinal vein occlusion: an ultrastructural analysis. Acta Ophthalmol. 2010;88(1):91-95

14. Prata TS, Rozenbaum I, DE MORAES CG, Lima VC, Liebmann J, Ritch R. Retinal vascular occlusions occur more frequently in the more affected eye in exfoliation syndrome. Eye (Lond). 2010;24(4):658-662

15. Lima VC, Prata TS, DE MORAES CG, Kim J, Seiple W, Rosen RB, Liebmann JM, Ritch R. A comparison between microperimetry and standard achromatic perimetry of the central visual field in eyes with glaucomatous paracentral visual field defects. Br J Ophthalmol. 2010;94(1):64-67

16. Castro DP, Prata TS, Lima VC, Biteli LG, DE MORAES CG, Paranhos A Jr. Corneal viscoelasticity differences between diabetic and nondiabetic glaucomatous patients. J Glaucoma. 2010;19(5):341-343

17. Lima VC, Prata TS, Castro DP, Castro LC, DE MORAES CG, Mattox C, Rosen RB, Liebmann JM, Ritch R. Macular changes detected by Fourier-domain optical coherence tomography in patients with hypotony without clinical maculopathy. Acta Ophthalmol. 2011;89(3):274-277

18. Ahrlich K, DE MORAES CG, Teng CC, Prata TS, Tello C, Ritch R, Liebmann JM. Visual Field Progression Differences between Normal-Tension and Exfoliative High-Tension Glaucoma Patients. Invest Ophthalmol Vis Sci. 2010;51:1458-1463

19. Teng CC, DE MORAES CG, Prata TS, Tello C, Ritch R, Liebmann JM. Beta-zone parapapillary atrophy and the velocity of glaucoma progression. Ophthalmology. 2010;117(5):909-915

20. Folgar FA, DE MORAES CG, Prata TS, Teng CC, Tello C, Ritch R, Liebmann JM. Glaucoma surgery decreases the rates of localized and global visual field progression. Am J Ophthalm 2010;149:258-264

21. De Beaufort HC, DE MORAES CG, Prata TS, Teng CC, Tello C, Ritch R, Liebmann JM. Recurrent disc hemorrhage does not increase the rate of visual field progression. Graefes Arch Clin Exp Ophthalmol. 2010;248(6):839-844

22. Tello C, DE MORAES CG, Prata TS, Derr P, Patel J, Siegfried J, Liebmann JM, Ritch R. Repeatability of short-duration transient visual evoked potentials in normal subjects. Doc Ophthalmol. 2010;120(3):219-228

23. DE MORAES CG, Ritch R, Liebmann JM. Modified visual field trend analysis. J Glaucoma. 2011;20(4):203-206

24. Anand A, DE MORAES CG, Tello C, Liebmann JM, Ritch R. Corneal hysteresis and visual field asymmetry in open angle glaucoma. Invest Ophthalmol Vis Sci. 2010;51(12):6514-6518

25. Park SC, DE MORAES CG, Liebmann JM, Ritch R. In-Vivo microstructural anatomy of beta-zone parapapillary atrophy in glaucoma. Invest Ophthalmol Vis Sci. 2010;51(12):6408-6413

26. Xin D, Greenstein VC, Ritch R, Liebmann JM, DE MORAES CG, Hood DC. A comparison of functional and structural measures for identifying progression of glaucoma. Invest Ophthalmol Vis Sci. 2011;52(1):519-526

27. Hood DC, Raza AS, DE MORAES CG, Odel JG, Greenstein VC, Liebmann JM, Ritch R. Initial arcuate defects within the central 10 degrees in glaucoma. Invest Ophthalmol Vis Sci. 2011;52(2):940-946

28. DE MORAES CG, Juthani V, Teng CC, Tello C, Susanna Jr. R, Ritch R.Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol. 2011;129(5):562-568

29. Prata TS, Lima VC, DE MORAES CG, Guedes LM, Magalhães FP, Teixeira SH, Ritch R, Paranhos A Jr. Factors associated with topographic changes of the optic nerve head induced by acute intraocular pressure reduction in glaucoma patients. Eye (Lond). 2011;25(2):201-207

30. Syed ZA, Radcliffe NM, DE MORAES CG, Liebmann JM, Ritch R. Detection of progressive glaucomatous optic neuropathy using automated alternation flicker with stereophotography. Arch Ophthalmol. 2011;129(4):521-522.

31. Prata TS, Lima VC, DE MORAES CG, Trubnik V, Derr P, Liebmann JM, Ritch R, Tello C. Short duration transient visual evoked potentials in glaucomatous eyes. J Glaucoma. 2012;21(6):415-420.

32. Forchheimer I, DE MORAES CG, Teng CC, Folgar F, Tello C, Ritch R, Liebmann JM.Baseline mean deviation and rates of visual field change in treated glaucoma patients. Eye (Lond). 2011;25:626-632

33. Zhang X, Bregman CJ, Raza AS, DE MORAES CG, Hood DC. Deriving visual field loss based upon OCT of inner retinal thicknesses of the macula. Biomed Opt Express. 2011;2(6):1734-1742

34. Syed ZA, Radcliffe NM, DE MORAES CG, Smith SD, Liebmann JM, Ritch R. Automated alternation flicker for the detection of optic disc haemorrhages. Acta Ophthalmol. 2012;90(7):645-650

35. Folgar FA, DE MORAES CG, Teng CC, Tello C, Ritch R, Liebmann JM. Effect of successful and partly successful filtering surgery on the velocity of glaucomatous visual field progression. J Glaucoma. 2012;21(9):615-618

36. DE MORAES CG, Hill V, Tello C, Liebmann JM, Ritch R. Lower corneal hysteresis is associated with more rapid glaucomatous visual field progression. J Glaucoma. 2012;21(4):209-213

37. Park SC, DE MORAES CG, Teng CC, Tello C, Liebmann JM, Ritch R. Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics. Ophthalmology. 2011;118(9):1782-1789

38. DE MORAES CG, Ketner S, Teng CC, Ehrlich JR, Raza AS, Liebmann JM, Ritch R, Hood DC. Beta-zone parapapillary atrophy and multifocal visual evoked potentials in eyes with glaucomatous optic neuropathy. Doc Ophthalmol. 2011;123(1):43-50

39. Teng CC, DE MORAES CG, Prata TS, Liebmann CA, Tello C, Ritch R, Liebmann JM. The region of largest β-zone parapapillary atrophy area predicts the location of most rapid visual field progression. Ophthalmology. 2011;118(12):2409-2413

40. DE MORAES CG, Liebmann CA, Susanna R Jr, Ritch R, Liebmann JM. Examination of the performance of different pointwise linear regression progression criteria to detect glaucomatous visual field change. Clin Experiment Ophthalmol. 2012;40(4):190-196

41. Hayes DD, Teng CC, DE MORAES CG, Tello C, Liebmann JM, Ritch R. Corneal hysteresis and beta-zone parapapillary atrophy. Am J Ophthalmol. 2012;153(2):358-362

42. Anand A, DE MORAES CG, Teng CC, Liebmann JM, Ritch R, Tello C. Short-duration transient visual evoked potential for objective measurement of refractive errors. Doc Ophthalmol. 2011;123(3):141-147

43. DE MORAES CG, Liebmann JM, Liebmann CA, Susanna R Jr, Tello C, Ritch R. Visual field progression outcomes in glaucoma subtypes. Acta Ophthalmol. 2013;91(3):288-293

44. Park SC, DE MORAES CG, Teng CC, Tello C, Liebmann JM, Ritch R. Enhanced depth imaging optical coherence tomography of deep optic nerve complex structures in glaucoma. Ophthalmology. 2012;119(1):3-9

45. Xin D, Talamini CL, Raza AS, DE MORAES CG, Greenstein VC, Liebmann JM, Ritch R, Hood DC. Hypodense regions (holes) in the retinal nerve fiber layer in frequency-domain OCT scans of glaucoma patients and suspects. Invest Ophthalmol Vis Sci. 2011;52(10):7180-186

46. Lima VC, DE MORAES CG, Gentile RC, Sidoti PA, Prata TS, Liebmann JM, Will DV, Tello C, Rosen R. Combined Baerveldt glaucoma implant and scleral buckling surgery for patients with retinal detachment and coexisting glaucoma. J Glaucoma. 2013;22(4):294-300

47. Raza AS, Cho J, DE MORAES CG, Wang M, Zhang X, Kardon RH, Liebmann JM, Ritch R, Hood DC. Retinal ganglion cell layer thickness and local visual field sensitivity in glaucoma. Arch Ophthalmol. 2011;129(12):1529-1536

48. DE MORAES CG, Sehi M, Greenfield DS, Chung YS, Ritch R, Liebmann JM A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients.. Invest Ophthalmol Vis Sci. 2012;53(6):2702-7.

49. DE MORAES CG, Demirel S, Gardiner SK, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA, The Ocular Hypertension Treatment Study. Effect of treatment on the velocity of visual field progression in the Ocular Hypertension Treatment Study Observation Group. Invest Ophthalmol Vis Sci. 2012;53(4):1704-1709

50. Demirel S, DE MORAES CG, Gardiner SK, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA, The Ocular Hypertension Treatment Study. The rate of visual field change in the Ocular Hypertension Treatment Study (OHTS). Invest Ophthalmol Vis Sci. 2012;53(1):224-227

51. Schor KS, DE MORAES CG, Teng CC, Tello C, Liebmann JM, Ritch R. Rates of visual field progression in distinct optic disc phenotypes. Clin Experiment Ophthalmol. 2012;40(7):706-712

52. DE MORAES CG, Liebmann JM, Ritch R, Hood DC. Understanding disparities among diagnostic technologies in glaucoma. Arch Ophthalmol. 2012;130(7):833-840

53. DE MORAES CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T, the Low-Pressure Glaucoma Treatment Group. Risk factors for visual field progression in the Low-pressure Glaucoma Treatment Study. Am J Ophthalmol. 2012;154(4):702-711

54. DE MORAES CG, Demirel S, Gardiner SK, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA, The Ocular Hypertension Treatment Study. The rate of visual field progression in eyes with optic disc hemorrhages in the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2012;130(12):1541-1546

55. Prata TS, Lima VC, Guedes LM, Biteli LG, Teixeira SH, DE MORAES CG, Ritch R, Paranhos A Jr. Association between corneal biomechanical properties and optic nerve head morphology in newly diagnosed glaucoma patients. Clin Experiment Ophthalmol. 2012;40(7):682-688

56. Song C, DE MORAES CG, Forchheimer I, Prata TS, Ritch R, Liebmann JM. Risk calculation variability over time in ocular hypertensive subjects. J Glaucoma. 2014;23(1):1-4

57. DE MORAES CG, Liebmann JM, Ritch R, Hood DC. Clinical use of multifocal visual-evoked potentials in a glaucoma practice: a prospective study. Doc Ophthalmol. 2012;125(1):1-9

58. DE MORAES CG, Ghobraiel SR, Ritch R, Liebmann JM. Comparison of PROGRESSOR and Glaucoma Progression Analysis 2 to detect visual field progression in treated glaucoma patient.. Asia-Pac J Ophthalmol 2012;1:135-139

59. De A Moura AL, Raza AS, Lazow MA, DE MORAES CG, Hood DC. Retinal ganglion cell and inner plexiform layer thickness measurements in regions of severe visual field sensitivity loss in patients with glaucoma. Eye (Lond). 2012;26(9):1188-1193

60. DE MORAES CG, Liebmann JM, Park SC, Teng CC, Nemiroff J, Tello C, Ritch R. Optic disc progression and rates of visual field change in treated glaucoma. Acta Ophthalmol. 2013;91(2):86-91

61. Gardiner SK, Demirel S, DE MORAES CG, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA; Ocular Hypertension Treatment Study Group. Series length used during trend analysis affects sensitivity to changes in progression rate in the Ocular Hypertension Treatment Study. Invest Ophthalmol Vis Sci. 2013;54(2):1252-1259

62. Prata TS, Dorairaj S, DE MORAES CG, Mehta S, Sbeity Z, Tello C, Liebmann J, Ritch R. Is pre-operative ciliary body and iris anatomical configuration a predictor of malignant glaucoma development? Clin Experiment Ophthalmol. 2013;41(6):541-545

63. Hatanaka M, Alencar LM, DE MORAES CG, Susanna R. Reproducibility of intraocular pressure peak and fluctuation of the water drinking test. Clin Experiment Ophthalmol. 2013;41(4):355-359

64. DE MORAES CG, Demirel S, Gardiner SK, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA, The Ocular Hypertension Treatment Study. The rate of visual field progression in eyes with optic disc hemorrhages in the Ocular Hypertension Treatment Study. JAMA. 2013;309(5):425

65. Hood DC, Raza AS, DE MORAES CG, Johnson CA, Liebmann JM, Ritch R. The nature of macular damage in glaucoma as revealed by averaging optical coherence tomography data. Transl Vis Sci Technol. 2012;1(1):3

66. Hood DC, Wang DL, Raza AS, DE MORAES CG, Liebmann JM, Ritch R. The locations of circumpapillary glaucomatous defects seen on frequency-domain OCT scans. Invest Ophthalmol Vis Sci. 2013;54(12):7338-7343

67. Hood DC, Slobodnick A, Raza AS, DE MORAES CG, Teng CC, Ritch R. Early glaucoma involves both deep local, and shallow widespread, retinal nerve fiber damage of the macular region. Invest Ophthalmol Vis Sci. 2014;55(2):632-49

68. Raza AS, Zhang X, DE MORAES CG, Reisman CA, Liebmann JM, Ritch R, Hood DC. Improving glaucoma detection using spatially correspondent clusters of damage and by combining standard automated perimetry and optical coherence tomography. Invest Ophthalmol Vis Sci. 2014 Jan 29;55(1):612-24

69. DE MORAES CG, Song C, Liebmann JM, Simonson JL, Furlanetto RL, Ritch R. Defining 10-2 visual field progression criteria: exploratory and confirmatory factor analysis using pointwise linear regression. Ophthalmology. 2014;121(3):741-9

70. Radcliffe NM, Smith SD, Syed ZA, Park SC, Ehrlich JR, DE MORAES CG, Liebmann JM, Ritch R. Retinal blood vessel positional shifts and glaucoma progression. Ophthalmology. 2014;121(4):842-8

71. Susanna R Jr, DE MORAES CG, Alencar LM, Ritch R. Nd:YAG laser goniopuncture for late bleb failure after trabeculectomy with adjunctive mitomycin C. JAMA Ophthalmol. 2014;132(3):286-90

72. Traynis I, DE MORAES CG, Raza AS, Liebmann JM, Ritch R, Hood DC. Prevalence and nature of early glaucomatous defects in the central 10° of the visual field. JAMA Ophthalmol. 2014;132(3):291-7

73. Furlanetto RL, DE MORAES CG, Teng CC, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T; For the Low-pressure Glaucoma Treatment Study Group. Risk factors for optic disc hemorrhage in the Low-pressure Glaucoma Treatment Study. Am J Ophthalmol. 2014;157(5):945-52

74. Hood DC, Nguyen M, Ehrlich AC, Raza AS, Sliesoraityte I, DE MORAES CG, Ritch R, Schiefer U. A test of a model of glaucomatous damage of the macula with high-density perimetry: implications for the locations of visual field test points. Transl Vis Sci Technol. 2014;3(3):5

75. Charlson ME, DE MORAES CG, Link A, Wells MT, Harmon G, Peterson JC, Ritch R, Liebmann JM. Nocturnal systemic hypotension increases the risk of glaucoma progression. Ophthalmology. 2014;121(10):2004-12

76. DE MORAES CG, Furlanetto RL, Liebmann JM, Ritch R. A new index to monitor central visual field progression. Ophthalmology. 2014;121(8):1531-8

77. Faridi OS, Park SC, Kabadi R, Su D, DE MORAES CG, Liebmann JM, Ritch R. Effect of focal lamina cribrosa defect on glaucomatous visual field progression. Ophthalmology. 2014;121(8):1524-30

78. Hood DC, Raza AS, DE MORAES CG, Alhadeff PA, Idiga J, Blumberg DM, Liebmann JM, Ritch R. Evaluation of a one-page report to aid in detecting glaucomatous damage. Transl Vis Sci Technol. 2014;3(6):8

79. Susanna R Jr, DE MORAES CG, Cioffi GA, Ritch R. Why do people (still) go blind from glaucoma? Transl Vis Sci Technol. 2015;4(2):1

80. Babic M, DE MORAES CG, Hatanaka M, Ju G, Susanna R Jr. Reproducibility of the water drinking test in treated glaucomatous patients. Clin Experiment Ophthalmol. 2014 Sep 11 [Epub ahead of print]

81. Kaplan RI, DE MORAES CG, Cioffi GA, Al-Aswad LA, Blumberg DM. Comparative cost-effectiveness of the Baerveldt implant, trabeculectomy with mitomycin, and medical treatment. JAMA Ophthalmol. 2015 Mar 5 [Epub ahead of print]

82. Mansouri K, Medeiros FA, Liu JH, DE MORAES CG, Weinreb RN. Analysis of 24-Hour IOP-related pattern changes after medical therapy. J Glaucoma. 2015 Apr 3 [Epub ahead of print]

83. Rosique RG, Rosique MJ, DE MORAES CG. Gluteoplasty with autologous fat tissue: experience with 106 consecutive cases. Plast Reconstr Surg. 2015;135(5):1381-1389

84. Blumberg DM, Prager AJ, Liebmann JM, Cioffi GA, DE MORAES CG. Cost-Related Medication Nonadherence and cost-saving behaviors among patients with glaucoma before and after the implementation of Medicare Part D. JAMA Ophthalmol. 2015;133(9):985-96

85. Hood DC, Xin D, Wang D, Jarukatsetphorn R, Ramachandran R, Grillo LM, DE MORAES CG, Ritch R. A Region-of-interest approach for detecting progression of glaucomatous damage with Optical Coherence Tomography. JAMA Ophthalmol. 2015;133(12):1438-44

86. Wang DL, Raza AS, DE MORAES CG, Chen M, Alhadeff P, Jarukatsetphorn R, Ritch R, Hood DC. Central glaucomatous damage of the macula can be overlooked by conventional OCT retinal nerve fiber layer thickness analyses. Transl Vis Sci Technol. 2015;4(6):4

87. Jasien JV, Jonas JB, DE MORAES CG, Ritch R. Intraocular pressure rise in subjects with and without glaucoma during four common yoga positions. PLoS One. 2015;10(12):e0144505

88. DE MORAES CG, Jasien JV, Simon-Zoula S, Liebmann JM, Ritch R. Visual field change and 24-hour IOP-related profile with a contact lens sensor in treated glaucoma patients. Ophthalmology. 2016;123(4):744-53

89. Germano RA, Susanna R Jr, DE MORAES CG, Susanna BN, Susanna CN, Chibana MN. Effect of switching from latanoprost to bimatoprost in primary open-angle glaucoma patients who experienced intraocular pressure elevation during treatment. J Glaucoma. 2016;25(4):e359-66

90. Skaat A, DE MORAES CG, Bowd C, Sample PA, Girkin CA, Medeiros FA, Ritch R, Weinreb RN, Zangwill LM, Liebmann JM; Diagnostic Innovations in Glaucoma Study and African Descent and Glaucoma Evaluation Study Groups. African Descent and Glaucoma Evaluation Study (ADAGES): Racial Differences in Optic Disc Hemorrhage and Beta-Zone Parapapillary Atrophy. Ophthalmology. 2016;123(7):1476-83

91. Grillo LM, Wang DL, Ramachandran R, Ehrlich AC, DE MORAES CG, Ritch R, Hood DC. The 24-2 visual field test misses central macular damage confirmed by the 10-2 visual field test and optical coherence tomography. Transl Vis Sci Technol. 2016;5(2):15

92. Blumberg DM, DE MORAES CG, Liebmann JM, Garg R, Chen C, Theventhiran A, Hood DC. Technology and the glaucoma suspect. Invest Ophthalmol Vis Sci. 2016;57(9):80-5

93. Ren R, Ding J, Wang N, Teng CC, DE MORAES CG, Jonas JB, Ritch R. Clinical signs and characteristics of exfoliation syndrome and exfoliative glaucoma in northern China. Asia Pac J Ophthalmol (Phila). 2015;4(2):86-8

94. Paula AP, Paula JS, Silva MJ, Rocha EM, DE MORAES CG, Rodrigues ML. Effects of swimming goggles wearing on intraocular pressure, ocular perfusion pressure, and ocular pulse amplitude. J Glaucoma. 2016;25(10):860-864

95. Hood DC, De Cuir N, Blumberg DM, Liebmann JM, Jarukasetphon R, Ritch R, DE MORAES CG. A Single wide-field OCT protocol can provide compelling information for the diagnosis of early glaucoma. Transl Vis Sci Technol. 2016;5(6):4

96. Tanna AP, Rademaker AW, DE MORAES CG, Godfrey DG, Sarkisian SR Jr, Vold SD, Ritch R. Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial. BMC Ophthalmol. 2016;16(1):217

97. Thenappan A, DE MORAES CG, Wang DL, Xin D, Jarukasetphon R, Ritch R, Hood DC. Optical Coherence Tomography and Glaucoma Progression: A Comparison of a Region of Interest Approach to Average Retinal Nerve Fiber Layer Thickness. J Glaucoma. 2017;26(5):473-477

98. Alhadeff PA, DE MORAES CG, Chen M, Raza AS, Ritch R, Hood DC. The Association Between Clinical Features Seen on Fundus Photographs and Glaucomatous Damage Detected on Visual Fields and Optical Coherence Tomography Scans. J Glaucoma. 2017;26(5):498-504

99. Germano RA, DE MORAES CG, Susanna R Jr, Dantas DO, Neto ED. Evaluation of a Novel Visual Field Analyzer Application for Automated Classification of Glaucoma Severity. J Glaucoma. 2017;26(6):586-591

100. DE MORAES CG, Murphy JT, Kaplan CM, Reimann JJ, Skaat A, Blumberg DM, Al-Aswad L, Cioffi GA, Girkin CA, Medeiros FA, Weinreb RN, Zangwill L, Liebmann JM. β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study. JAMA Ophthalmol. 2017;135(6):617-623

101. Blumberg DM, DE MORAES CG, Prager AJ, Yu Q, Al-Aswad L, Cioffi GA, Liebmann JM, Hood DC. Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma. JAMA Ophthalmol. 2017;135(7):742-747

102. DE MORAES CG, Hood DC, Thenappan A, Girkin CA, Medeiros FA, Weinreb RN, Zangwill LM, Liebmann JM. 24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma. Ophthalmology. 2017;124(10):1449-1456

103. Prager AJ, Hood DC, Liebmann JM, DE MORAES CG, Al-Aswad LA, Yu Q, Cioffi GA, Blumberg DM. Association of Glaucoma-Related, Optical Coherence Tomography-Measured Macular Damage With Vision-Related Quality of Life. JAMA Ophthalmol. 2017;135(7):783-788

104. Liebmann K, DE MORAES CG, Liebmann JM. Measuring Rates of Visual Field Progression in Linear Versus Nonlinear Scales: Implications for Understanding the Relationship Between Baseline Damage and Target Rates of Glaucoma Progression. J Glaucoma. 2017;26(8):721-725

105. Vera J, Jiménez R, Redondo B, Cárdenas D, DE MORAES CG, Garcia-Ramos A. Intraocular Pressure Responses to Maximal Cycling Sprints Against Different Resistances: The Influence of Fitness Level. J Glaucoma. 2017;26(10):881-887

106. Wang M, Shen LQ, Boland MV, Wellik SR, DE MORAES CG, Myers JS, Bex PJ, Elze T. Impact of Natural Blind Spot Location on Perimetry. Sci Rep. 2017;7(1):6143

107. DE MORAES CG, Susanna R Jr, Sakata LM, Hatanaka M. Predictive Value of the Water Drinking Test and the Risk Glaucomatous Visual Field Progression. J Glaucoma. 2017;26(9):767-773

108. Muhammad H, Fuchs TJ, De Cuir N, DE MORAES CG, Blumberg DM, Liebmann JM, Ritch R, Hood DC. Hybrid Deep Learning on Single Wide-field Optical Coherence Tomography Scans Accurately Classifies Glaucoma Suspects. J Glaucoma. 2017;26(12):1086-1094

109. Theventhiran A, Shabsigh M, DE MORAES CG, Cioffi GA, Kamel M, Blumberg D, Al-Aswad LA. A Comparison of Retrobulbar Versus Topical Anesthesia in Trabeculectomy and Aqueous Shunt Surgery. J Glaucoma. 2018;27(1):28-32

110. Wang M, Pasquale LR, Shen LQ, Boland MV, Wellik SR, DE MORAES CG, Myers JS, Wang H, Baniasadi N, Silva RN, Bex PJ, Elze T. Reversal of the Glaucoma Hemifield Test to Normal after Two Consecutive Abnormal Results. Ophthalmology. 2018;125(3):352-360

111. Kreuz AC, DE MORAES CG, Hatanaka M, Oyamada MK, Monteiro MLR.Macular and Multifocal PERG and FD-OCT in Pre-perimetric and Hemifield Loss Glaucoma. J Glaucoma. 2018;27(2):121-132

112. Garg A, DE MORAES CG, Cioffi GA, Girkin CA, Medeiros FA, Weinreb RN, Zangwill L, Liebmann JM. Baseline 24-2 Central Visual Field Damage is Predictive of Global Progressive Field Loss. Am J Ophthalmol. 2018;187:92-98

113. Melgarejo JD, Lee JH, Petitto M, Yépez JB, Murati FA, Jin Z, Chávez CA, Pirela RV, Calmón GE, Lee W, Johnson MP, Mena LJ, Al-Aswad LA, Terwilliger JD, Allikmets R, Maestre GE, DE MORAES CG. Glaucomatous Optic Neuropathy Associated with Nocturnal Dip in Blood Pressure: Findings from the Maracaibo Aging Study. Ophthalmology. 2018 Jan 5 [Epub ahead of print]

114. Vera J, Garcia-Ramos A, Redondo B, Cárdenas D, DE MORAES CG, Jiménez R. Effect of a Short-term Cycle Ergometer Sprint Training Against Heavy and Light Resistances on Intraocular Pressure Responses. J Glaucoma. 2018;27(4):315-321

115. Mavrommatis MA, Wu Z, Naegele SI, Nunez J, DE MORAES CG, Ritch R, Hood DC. Deep Defects Seen on Visual Fields Spatially Correspond Well to Loss of Retinal Nerve Fiber Layer Seen on Circumpapillary OCT Scans. Invest Ophthalmol Vis Sci. 2018;59(2):621-628

116. DE MORAES CG, Muhammad H, Kaur K, Wang D, Ritch R, Hood DC. Interindividual variations in foveal anatomy and artifacts seen on inner retinal probability maps from spectral domain OCT Scans of the macula. Transl Vis Sci Technol. 2018;7(2):4

117. DE MORAES CG, Pettito M, Yepez JB, Sakuntabhai A, Simon-Loriere E, Zaidi MB, Prot M, Ruffie C, Kim SS, Allikmets R, Terwilliger JD, Lee JH, Maestre GE. Optic neuropathy and congenital glaucoma associated with probable Zika virus infection in Venezuelan patients. JMM Case Rep. 2018;5(5):e00514

118. DE MORAES CG, Mansouri K, Liebmann JM, Ritch R; Triggerfish Consortium. Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma. JAMA Ophthalmol. 2018;136(7):779-785

119. Senger C, da Silva MJL, DE MORAES CG, Messias A, Paula JS. Spatial correlation between localized decreases in exploratory visual search performance and areas of glaucomatous visual field loss. Graefes Arch Clin Exp Ophthalmol. 2019;257(1):153-160

120. Lee MJ, Wang J, Friedman DS, Boland MV, DE MORAES CG, Ramulu PY. Greater physical activity is associated with slower visual field loss in glaucoma. Ophthalmology. 2018 Oct 10. [Epub ahead of print]

121. Vera J, Jiménez R, Redondo B, Torrejón A, DE MORAES CG, García-Ramos A. Effect of the level of effort during resistance training on intraocular pressure. Eur J Sport Sci. 2019;19(3):394-401

122. Akagi T, Saunders LJ, Shoji T, DE MORAES CG, Skaat A, Manalastas PI, Girkin CA, Liebmann JM, Zangwill LM, Weinreb RN. Association between Rates of Retinal Nerve Fiber Layer Thinning and Previous Disc Hemorrhage in Glaucoma. Ophthalmology Glaucoma 2018;1(1):23-31

123. Susanna CN, Susanna R, Hatanaka M, Susanna BN, Susanna FN, DE MORAES CG. Comparison of Intraocular Pressure Changes during the Water Drinking Test between Different Fluid Volumes in Patients with Primary Open Angle Glaucoma. J Glaucoma. 2018;27(11):950-956

124. Hao Z, Wang Z, Li Y, Zhu Y, Wang X, DE MORAES CG, Pan Y, Zhao X, Lin Q. Measurement of cytokine biomarkers using an aptamer-based affinity graphene nanosensor on a flexible substrate toward wearable applications. Nanoscale. 2018;10(46):21681-21688

125. DE MORAES CG, Sun A, Jarukasetphon R, Rajshekhar R, Shi L, Blumberg DM, Liebmann JM, Ritch R, Hood DC. Association of Macular Visual Field Measurements With Glaucoma Staging Systems. JAMA Ophthalmol. 2018 Nov 8 [Epub ahead of print]

126. Lee MJ, Wang J, Friedman DS, Boland MV, DE MORAES CG, Ramulu PY. Greater Physical Activity Is Associated with Slower Visual Field Loss in Glaucoma. Ophthalmology. 2018 Oct 10 [Epub ahead of print]

127. Mavrommatis MA, De Cuir N, Reynaud J, DE MORAES CG, Xin D, Rajshekhar R, Liebmann JM, Ritch R, Fortune B, Hood DC. An Examination of the Frequency of Paravascular Defects and Epiretinal Membranes in Eyes With Early Glaucoma Using En-face Slab OCT Images. J Glaucoma. 2019;28(3):265-269

128. Saeedi OJ, Elze T, D'Acunto L, Swamy R, Hegde V, Gupta S, Venjara A, Tsai J, Myers JS, Wellik SR, DE MORAES CG, Pasquale LR, Shen LQ, Boland MV. Agreement and Predictors of Discordance of Six Visual Field Progression Algorithms. Ophthalmology. 2019 [Epub ahead of print]

129. Maeng MM, DE MORAES CG, Winn BJ, Dagi LRG. Effect of Topical Periocular Steroid Use on Intraocular Pressure: A Retrospective Analysis. Ophthalmic Plast Reconstr Surg. 2019 [Epub ahead of print]

130. Wang M, Shen LQ, Pasquale LR, Petrakos P, Formica S, Boland MV, Wellik SR, DE MORAES CG, Myers JS, Saeedi O, Wang H, Baniasadi N, Li D, Tichelaar J, Bex PJ, Elze T. An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis. Invest Ophthalmol Vis Sci. 2019;60(1):365-375.

131. Cutolo CA, DE MORAES CG, Liebmann JM, Mansouri K, Traverso CE, Ritch R; Triggerfish Consortium. The Effect of Therapeutic IOP-lowering Interventions on the 24-hour Ocular Dimensional Profile Recorded With a Sensing Contact Lens. J Glaucoma. 2019;28(3):252-257

132. Lee SH, Joiner DB, Tsamis E, Rajshekhar R, Kim E, DE MORAES CG, Ritch R, Hood DC. Optical coherence tomography circle scans can be used to study many eyes with advanced glaucoma. Ophthalmology Glaucoma 2019 [Epub ahead of print]

133. Vera J, Jiménez R, Redondo B, Torrejón A, Koulieris GA, De Moraes CG, García-Ramos A. Investigating the Immediate and Cumulative Effects of Isometric Squat Exercise for Different Weight Loads on Intraocular Pressure: A Pilot Study. Sports Health. 2019 Apr 15 [Epub ahead of print]

Reviews, Perspectives, and Editorials:

134. DE MORAES CG, Ritch R, Liebmann JM. Bridging the major prospective national eye institute-sponsored glaucoma clinical trials and clinical practice. J Glaucoma. 2011;20(1):1-2

135. DE MORAES CGV, Prata TS, Liebmann JM, Ritch R Modalities of tonometry and their accuracy with respect to corneal thickness and corneal irregularities. Journal of Optometry, 2008;1:43-49

136. DE MORAES CG, Liebmann JM, Susanna Jr. R. Does structural damage precede functional loss in glaucoma? Expert Rev. Ophthalmol. 2010;5(4):451-462

137. Prata TS, DE MORAES CG, Kanadani FN, Ritch R, Paranhos A Jr. Posture-induced intraocular pressure changes: considerations regarding body position in glaucoma patients. Surv Ophthalmol. 2010;55(5):445-453

138. DE MORAES CG, Susanna R Jr, Ritch R. The water drinking test. Am J Ophthalmol. 2011;151(3):559-560

139. Hood DC, Raza AS, DE MORAES CG, Liebmann JM, Ritch R. Glaucomatous damage of the macula. Prog Retina Eye Res. 2013;32:1-21

140. DE MORAES CG. Anatomy of the visual pathways. J Glaucoma. 2013; Suppl 5:S2-7

141. DE MORAES CG. Future direction of research: glaucoma and the brain. J Glaucoma. 2013;Suppl 5:S51-3

142. DE MORAES CG, Liebmann JM, Medeiros FA, Weinreb RN. Management of advanced glaucoma: characterization and monitoring. Surv Ophthalmol. 2016:S0039-6257(15)30047-3

143. DE MORAES CG, Liebmann JM, Levin LA. Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma. Prog Retin Eye Res. 2017;56:107-147

144. Senger C, Margarido MRRA, DE MORAES CG, De Fendi LI, Messias A, Paula JS. Visual Search Performance in Patients with Vision Impairment: A Systematic Review. Curr Eye Res. 2017:1-11

145. Hood DC, DE MORAES CG. Challenges to the Common Clinical Paradigm for Diagnosis of Glaucomatous Damage With OCT and Visual Fields. Invest Ophthalmol Vis Sci. 2018;59(2):788-791

146. DE MORAES CG. Commentary: The importance of combining structure and function to measure rates of progression in glaucoma. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1225-1226

147. Hood DC, DE MORAES. Commentary: Efficacy of a Deep Learning System for Detecting Glaucomatous Optic Neuropathy Based on Color Fundus Photographs. Ophthalmology. 2018;125(8):1207-1208

148. Hood Dc, DE MORAES. Perspective: Four questions every clinician diagnosing and/or treating glaucoma should ask. J Glaucoma. 2018;27(8):657-664

149. DE MORAES CG, Cioffi GA, Weinreb RN, Liebmann JM. Perspective: New Recommendations for the Treatment of Systemic Hypertension and their Potential Implications for Glaucoma Management. J Glaucoma. 2018;27(7):567-571.

Case Reports/ Case Series:

150. DE MORAES CG, Facio Jr AC, Costa JH, Malta RFS. Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series. Journal of Ocular Biology, Diseases and Informatics 2009; 2:40-46

151. Prata TS, Palmiero PM, DE MORAES CG, Tello C, Sbeity Z, Liebmann J, Ritch R. Imaging of a traumatic cyclodialysis cleft in a child using slit-lamp-adapted optical coherence tomography. Eye 2009;23:1618-1619

152. Prata TS, Palmiero PM, DE MORAES CG, Tello C, Liebmann J, Ritch R. Slit-lamp-adapted optical coherence tomography for assessment of an overhanging filtering bleb. Acta Ophthalmol. 2010;88(8):910-911

153. Kiumehr S, Schor KS, DE MORAES CG, Liebmann JM, Ritch R. Ultrasound biomicroscopy of congenital iris flocculi. Clin Experiment Ophthalmol. 2012;40(3):323-325

154. Zaidi MB, DE MORAES CG, Petitto M, Yepez JB, Sakuntabhai A, Simon-Loriere E, Prot M, Ruffie C, Kim SS, Allikmets R, Terwilliger JD, Lee JH, Maestre GE. Non-congenital severe ocular complications of Zika virus infection. JMM Case Rep. 2018;5(6):e005152.

Books and Book Chapters:

1. DE MORAES CG, Hatanaka M, Babic M, Vessani, RM, Susanna Jr. The Glaucomas. In: Clínica Médica vol. 6, Ed. Manole, São Paulo, Brazil, 2009

2. DE MORAES CG, Kara-Jose N. ICE Syndromes. In: Diseases of the Cornea and Conjuntiva (Brazilian Council of Ophthalmology Collection), Sao Paulo, Brazil, 2007

3. DE MORAES CG, Susanna Jr R. Traumatic Glaucoma. In: Jules Stein Pearls of Glaucoma Management. Verlag-Springer GmbH, Berlin and Heidelberg, Germany, 2010, pp. 348-353

4. DE MORAES CG, Susanna Jr R. Pigmentary Glaucoma. In: Jules Stein Pearls of Glaucoma Management. Verlag-Springer GmbH, Berlin and Heidelberg, Germany, 2010, pp. 345-348

5. DE MORAES CG, Susanna Jr R. Cataract Surgery in Nanophthalmous. In: Cataract Surgery in the Glaucoma Patient. Springer. Verlag-Springer GmbH, Berlin and Heidelberg, Germany, 2010, pp. 197-205

6. DE MORAES CG. Treatment Goals. In: Medical Treatment of Glaucoma, World Glaucoma Association Consensus Series

7. RN Weinreb, M Araie, R Susanna, I Goldberg, C Migdal, JM Liebmann. Kugler Publications, Amsterdam, Netherlands, 2010 7. DE MORAES CG. Structure and Function. In: Progression of Glaucoma, World Glaucoma Association Consensus Series

8. RN Weinreb, DF Garway-Heath, C Leung, JG Crowston, FA Medeiros. Kugler Publications, Amsterdam, Netherlands, 2011 8. DE MORAES CG, Hatanaka M, Susanna R. Other Glaucoma Implants and Pearls for Tube Implantation. In: Glaucoma Medical Diagnosis and Therapy: Expert Consult, 2nd Edition. TM. Shaarawy, MB Sherwood, JG Crowston, RA Hitchings. Saunders Ltd., Elsevier, London, UK, 2013

9. DE MORAES CG. Adaptive Optics Scanning Laser Polarimetry. In: Optical Coherence Tomography in Glaucoma. Silva FA, Guedes VR, Silva NA. Cultura Medica. Sao Paulo, Brazil, 2017